Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
, L- '
In AWARD-10 [31], a 24-week, randomized, double-blind, placebo-controlled trial evaluating once-weekly dulaglutide (administered at either 1.5 or 0.75 mg) as add-on therapy to SGLT2is in a total of 424 patients with inadequately controlled T2DM, only one episode of severe hypoglycemia was reported throughout the study, in a patient treated with dulaglutide 0.75 mg, confirming the very low incidence of serious hypoglycemia with GLP-1RAs in combination with SGLT2is [31]
The Unstoppable Rise of GLP-1 Agonists: Revolutionising Diabetes and Obesity Treatment Over the past two years, the pharmaceutical industry has witnessed an unprecedented surge in the development and deployment of GLP-1 receptor agonists
Consistent Medication Supply Established clinics and medical providers typically have more reliable access to FDA-approved medications
US$ 20.71
US$ 27.02
US$ 20.62
US$ 20.94
US$ 21.19
US$ 23.12
US$ 25.05
US$ 27.91
